Ontology highlight
ABSTRACT: Introduction
Multidrug-resistant tuberculosis (MDR-TB) remains a major public health problem globally. Long, complex treatment regimens coupled with frequent adverse events have resulted in poor treatment adherence and patient outcomes. Smartphone-based mobile health (mHealth) technologies offer national TB programmes an appealing platform to improve patient care and management; however, clinical trial evidence to support their use is lacking. This trial will test the hypothesis that an mHealth intervention can improve treatment success among patients with MDR-TB and is cost-effective compared with standard practice.Methods and analysis
A community-based, open-label, parallel-group randomised controlled trial will be conducted among patients treated for MDR-TB in seven prov
SUBMITTER: Velen K
PROVIDER: S-EPMC9226862 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature